BioNTech announces $209M net loss in Q2

ISTANBUL

Pharmaceutical company BioNTech announced a net loss of €190.4 million ($209.2 million) in the second quarter of 2023, the company announced on Monday.

The firm's revenues dropped around 95% to €167.7 million in the April-June period, down from €3.2 billion in the same quarter last year, BioNTech said in a press release.

The firm has saw a net profit of $1.67 billion in the second quarter of 2022.

For the first half, it saw a net profit of €311.8 million, down from $5.37 billion a year ago.

The firm's revenues totaled €1.44 billion in the January-June period, decreasing from €9.57 billion.